Sanofi S.A.

There are seven coronavirus vaccine candidates being tested in the U.S. — here’s where they stand

8:38 a.m. Oct. 14, 2020

- Jaimy Lee

There are four coronavirus vaccines in late-stage studies — here’s how they differ

7:27 a.m. Sept. 28, 2020

- Jaimy Lee

Banks slump in Europe as stocks lurch toward worst week since June

8:25 a.m. Sept. 25, 2020

- Barbara Kollmeyer

Coronavirus update: U.S. death toll passes 200,000, as new cases rose by more than 50,000 in a day

3:21 p.m. Sept. 22, 2020

- Tomi Kilgore

Sanofi, GlaxoSmithKline signs deal with Canada to deliver 72 million doses of potential COVID-19 vaccine

12:53 p.m. Sept. 22, 2020

- Tomi Kilgore

Coronavirus update: Global case tally tops 30 million, and controversial CDC testing guideline changes were reportedly not made by CDC scientists

3:29 p.m. Sept. 18, 2020

- Ciara Linnane

Coronavirus update: Global case tally tops 27.3 million, and U.S. accounts for a quarter, as 9 drug-company CEOs pledge to ‘stand with science’ in vaccine development

3:59 p.m. Sept. 8, 2020

- Ciara Linnane

Group of 9 drug company CEOs pledge to make sure COVID-19 vaccine follows full regulatory path

6:44 a.m. Sept. 8, 2020

- Ciara Linnane

Coronavirus update: Global tally climbs above 26 million, U.S. above 6.1 million, amid concerns CDC will rush out a vaccine

6:03 a.m. Sept. 4, 2020

- Ciara Linnane

Sanofi, GSK's coronavirus vaccine candidate enters clinical trials

7:59 a.m. Sept. 3, 2020

- Jaimy Lee

Surge in megadeals points to M&A recovery as tech sector dominates

10:41 a.m. Sept. 2, 2020

- Lina Saigol

Coronavirus update: Global case tally tops 25.5 million, and U.S. climbs to 6.03 million as Midwest states suffer rise in infections

2:49 p.m. Sept. 1, 2020

- Ciara Linnane

Sanofi, Regeneron: Kevzara fails in late-stage COVID-19 trial

8:39 a.m. Sept. 1, 2020

- Jaimy Lee

Sanofi looks to accelerate MS treatment with $3.68 billion acquisition of Principia Biopharma

2:05 p.m. Aug. 17, 2020

- Lina Saigol

Russia’s accelerated COVID-19 vaccine greeted with alarm as experts say Phase 3 trial is essential

8:38 a.m. Aug. 12, 2020

- Ciara Linnane

The stock market will be flying high in a year — for 2 simple reasons

11:18 a.m. Aug. 5, 2020

- Michael Brush

Coronavirus update: U.S. death toll climbs to 155,000, as COVID-19 enters ‘dangerous new phase’

3:31 p.m. Aug. 3, 2020

- Ciara Linnane

Coronavirus update: Pandemic will continue for some time, experts tell Congress as U.S. case tally nears 4.5 million

11:28 a.m. July 31, 2020

- Ciara Linnane

Sanofi and GlaxoSmithKline in talks with EC, France and Italy on global access to COVID-19 vaccine

7:09 a.m. July 31, 2020

- Ciara Linnane

Sanofi and GlaxoSmithKline to receive $2.1 bln in U.S. government funding for trials

7:09 a.m. July 31, 2020

- Ciara Linnane

Big Drugmakers Pay Big Prices for Promising Biotechs

8:12 a.m. Jan. 23, 2018

- The Wall Street Journal Interactive Edition

Sanofi to Buy Hemophilia Drugmaker Bioverativ for Over $11.5 Billion

10:54 a.m. Jan. 22, 2018

- The Wall Street Journal Interactive Edition

Philippines Probes Dengue Vaccination Drive That Went Ahead Despite Warnings

12:03 p.m. Dec. 18, 2017

- The Wall Street Journal Interactive Edition

FDA Panel Expands Flu Vaccine

9:31 p.m. Feb. 27, 2013

- The Wall Street Journal Interactive Edition

Many Past Espionage Cases Had Links to China

12:28 p.m. Feb. 21, 2013

- The Wall Street Journal Interactive Edition

French Stock Benchmark Regains Its Spring

8:55 p.m. Feb. 29, 2012

- The Wall Street Journal Interactive Edition

FDA Restricts Use of Multaq

4:49 p.m. Dec. 19, 2011

- The Wall Street Journal Interactive Edition

In 2012, Slow Return to European Stocks

10:26 p.m. Dec. 18, 2011

- The Wall Street Journal Interactive Edition

Sanofi Profit Climbs 26%

3:32 p.m. Nov. 3, 2011

- The Wall Street Journal Interactive Edition

Sanofi Offers Bonuses to Retain Genzyme Scientists

9:44 a.m. April 28, 2011

- The Wall Street Journal Interactive Edition

Roche Sales Fall 9%

4:08 p.m. April 14, 2011

- The Wall Street Journal Interactive Edition

Key Drugs Boost AstraZeneca

5:17 a.m. July 29, 2010

- The Wall Street Journal Interactive Edition

Corporate Watch

10:16 p.m. April 6, 2010

- The Wall Street Journal Interactive Edition

Sanofi Settles More Patent Suits

7:27 a.m. April 6, 2010

- The Wall Street Journal Interactive Edition

Earnings Watch

8:36 p.m. Feb. 10, 2010

- The Wall Street Journal Interactive Edition

Key Drug Sales, Vaccines Boost Sanofi

11:13 a.m. Feb. 10, 2010

- The Wall Street Journal Interactive Edition

Energy Firms Lead European Markets

1:45 p.m. Dec. 21, 2009

- The Wall Street Journal Interactive Edition

Bristol-Myers to Split Off Mead

8:00 a.m. Nov. 16, 2009

- The Wall Street Journal Interactive Edition

Weak Data Weigh Down Europe's Indexes

12:45 p.m. Sept. 1, 2009

- The Wall Street Journal Interactive Edition

European Shares Follow Asia Lower

8:06 p.m. Aug. 31, 2009

- The Wall Street Journal Interactive Edition